Doctor-led multi-specialty hospital network (Medanta) with tertiary/quaternary care across 6 Indian cities.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 49 | 50 | 51 | 54 | 54 | 54 | 54 | 54 |
| Reserves | 1.3k | 1.3k | 1.6k | 2.4k | 2.9k | 3.3k | 3.7k | 3.9k |
| Borrowings | 929 | 931 | 1.1k | 1.1k | 802 | 718 | 945 | 1.2k |
| Other Liabilities | 388 | 380 | 421 | 547 | 572 | 662 | 757 | 753 |
| Total Liabilities | 2.7k | 2.7k | 3.1k | 4.1k | 4.3k | 4.8k | 5.4k | 5.9k |
| AssetsFixed Assets | 1.7k | 1.6k | 1.8k | 2.0k | 2.2k | 2.5k | 3.2k | 3.8k |
| CWIP | 382 | 464 | 439 | 327 | 388 | 533 | 318 | 132 |
| Investments | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 3 |
| Other Assets | 581 | 615 | 930 | 1.7k | 1.7k | 1.7k | 1.9k | 2.0k |
| Total Assets | 2.7k | 2.7k | 3.1k | 4.1k | 4.3k | 4.8k | 5.4k | 5.9k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 166 | 175 | 242 | 311 | 645 | 612 | 624 | 714 |
| Cash from Investing | -249 | -87 | -239 | -421 | -342 | -441 | -721 | -1.1k |
| Cash from Financing | 97 | -1 | -81 | 160 | 346 | -514 | -97 | 272 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -133 | -13 | 100 | 38 | 409 | 335 | 110 | -263 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (57.1×) and current (61.1×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 19.2% growth and a 57× exit, ₹1266 only delivers your return if you pay ₹1,275. The price is currently baking in 19% growth.
EPS grows 19.2%/yr for 5 years, then fades to 6% over 2, exits at 57×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 19.2% | 24.69 |
| FY28 | 19.2% | 29.43 |
| FY29 | 19.2% | 35.08 |
| FY30 | 19.2% | 41.81 |
| FY31 | 19.2% | 49.84 |
| FY32 | 12.6% ·fade | 56.12 |
| FY33 | 6.0% ·fade | 59.48 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.